Original document(120 pages)  中文版
    A compound having excellent macrophage activity inhibitory action, which is represented by the general following formula: [wherein Q represents an oxygen atom, a C 1 -C 3 alkylene group, a -O-Alk- group or a -O-Alk-O- group (in which Alk is a C 1 -C 3 alkylene group), R 1 represents a C 1 -C 20 alkanoyl group which may be substituted, a C 3 -C 20 alkenoyl group which may be substituted or a C 3 -C 20 alkynoyl group which may be substituted, R 2 , R 3 and R 4 , which may be the same or different, represent a hydrogen atom, a C 1 -C 20 alkyl group which may be substituted, a C 2 -C 20 alkenyl group which may be substituted, a C 2 -C 20 alkynyl group which may be substituted, a C 1 -C 20 alkanoyl group which may be substituted, a C 3 -C 20 alkenoyl group which may be substituted or a C 3 -C 20 alkynoyl group which may be substituted, R 5 represents a hydrogen atom, a halogen atom, a hydroxyl group, a C 1 -C 6 alkoxy group which may be substituted, a C 2 -C 6 alkenyloxy group which may be substituted or a C 2 -C 6 alkynyloxy group which may be substituted, and W represents an oxygen atom or a -NH- group], or a pharmacologically acceptable salt thereof.
Application Number
申请号
200580007429 Application Date
申请日
2005.01.07
Title 名称 L-saccharide glucose lipid a analogue
Publication Number
公开号
1930180 Publication Date
公开日
2007.03.14
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07H15/04;C07H15/10;A61P9/00;A61P29/00;A61P31/04;A61P37/02;A61P37/06;A61P43/00
Applicant(s) Name
申请人
Sankyo Co.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 xiongyu lan wujuan
More information 更  多  信  息


 Related patents information
Lipid A analogs having immunoactivating and anti-tumor activity
Ether type lipid A1-carboxylic acid analogues
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.